Screener
Medtronic MDT Payments for Repurchase of Common Stock
Payments for Repurchase of Common Stock at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.
The source filing: Medtronic’s 10-K, filed June 18, 2026.
- Filed
- Jun 18, 2026, 4:27 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-044354
| (in millions) | Fiscal Year / 2026 | Fiscal Year / 2025 | Fiscal Year / 2024 |
|---|---|---|---|
| Payments on long-term debt | (2,930) | — | — |
| Dividends to shareholders | (3,639) | (3,589) | (3,666) |
| Issuance of ordinary shares | 516 | 508 | 284 |
| Repurchase of ordinary shares | (1,035) | (3,235) | (2,138) |
| Proceeds from MiniMed initial public offering | 538 | — | — |
| Other financing activities, net | 44 | (184) | (3) |
| Net cash used in financing activities | (4,751) | (4,361) | (4,450) |
| Effect of exchange rate changes on cash and cash equivalents | 85 | 188 | (230) |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Medtronic's payments for repurchase of common stock?
- Medtronic (MDT) reported payments for repurchase of common stock of $435M in Q1 2026.
- How has Medtronic's payments for repurchase of common stock changed year-over-year?
- Medtronic's payments for repurchase of common stock increased by 58.8% year-over-year, from $274M to $435M.
- What is the long-term trend for Medtronic's payments for repurchase of common stock?
- Over 4 years (2022 to 2026), Medtronic's payments for repurchase of common stock has grown at a -20.1% compound annual growth rate (CAGR), from $2.54B to $1.04B.
Ask your AI about Medtronic's payments for repurchase of common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude